| pubmed-article:15812536 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15812536 | lifeskim:mentions | umls-concept:C0001486 | lld:lifeskim |
| pubmed-article:15812536 | lifeskim:mentions | umls-concept:C0008059 | lld:lifeskim |
| pubmed-article:15812536 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:15812536 | lifeskim:mentions | umls-concept:C1504389 | lld:lifeskim |
| pubmed-article:15812536 | lifeskim:mentions | umls-concept:C0011900 | lld:lifeskim |
| pubmed-article:15812536 | lifeskim:mentions | umls-concept:C0020964 | lld:lifeskim |
| pubmed-article:15812536 | lifeskim:mentions | umls-concept:C1515895 | lld:lifeskim |
| pubmed-article:15812536 | pubmed:dateCreated | 2005-4-6 | lld:pubmed |
| pubmed-article:15812536 | pubmed:abstractText | Human adenoviruses (HAdV) are a frequent cause of potentially fatal infections in patients after allogeneic stem cell transplantation, especially in children. Monitoring of serum/plasma by real-time quantitative PCR is a sensitive tool for the recognition of patients at risk of a potentially fatal infection and for the evaluation of the efficacy of treatment. Data from a retrospective study and from a prospective study demonstrate that recovery of immunity after transplantation is essential for the elimination of HAdV infection. The feasibility of several approaches for the manipulation of immunity in the immunocompromised host to prevent a fatal course of the infection is discussed. | lld:pubmed |
| pubmed-article:15812536 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15812536 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15812536 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15812536 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15812536 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15812536 | pubmed:month | Mar | lld:pubmed |
| pubmed-article:15812536 | pubmed:issn | 0268-3369 | lld:pubmed |
| pubmed-article:15812536 | pubmed:author | pubmed-author:EgelerR MRM | lld:pubmed |
| pubmed-article:15812536 | pubmed:author | pubmed-author:SchilhamM WMW | lld:pubmed |
| pubmed-article:15812536 | pubmed:author | pubmed-author:LankesterA... | lld:pubmed |
| pubmed-article:15812536 | pubmed:author | pubmed-author:HeemskerkBB | lld:pubmed |
| pubmed-article:15812536 | pubmed:author | pubmed-author:van... | lld:pubmed |
| pubmed-article:15812536 | pubmed:author | pubmed-author:van TolM J... | lld:pubmed |
| pubmed-article:15812536 | pubmed:author | pubmed-author:ClaasE C JEC | lld:pubmed |
| pubmed-article:15812536 | pubmed:author | pubmed-author:KroesA C MAC | lld:pubmed |
| pubmed-article:15812536 | pubmed:author | pubmed-author:de KlerkE P... | lld:pubmed |
| pubmed-article:15812536 | pubmed:author | pubmed-author:SombroekC CCC | lld:pubmed |
| pubmed-article:15812536 | pubmed:author | pubmed-author:BeersmaM F... | lld:pubmed |
| pubmed-article:15812536 | pubmed:author | pubmed-author:Veltrop-Duits... | lld:pubmed |
| pubmed-article:15812536 | pubmed:author | pubmed-author:de BrouwerC... | lld:pubmed |
| pubmed-article:15812536 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15812536 | pubmed:volume | 35 Suppl 1 | lld:pubmed |
| pubmed-article:15812536 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15812536 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15812536 | pubmed:pagination | S73-6 | lld:pubmed |
| pubmed-article:15812536 | pubmed:dateRevised | 2005-11-16 | lld:pubmed |
| pubmed-article:15812536 | pubmed:meshHeading | pubmed-meshheading:15812536... | lld:pubmed |
| pubmed-article:15812536 | pubmed:meshHeading | pubmed-meshheading:15812536... | lld:pubmed |
| pubmed-article:15812536 | pubmed:meshHeading | pubmed-meshheading:15812536... | lld:pubmed |
| pubmed-article:15812536 | pubmed:meshHeading | pubmed-meshheading:15812536... | lld:pubmed |
| pubmed-article:15812536 | pubmed:meshHeading | pubmed-meshheading:15812536... | lld:pubmed |
| pubmed-article:15812536 | pubmed:meshHeading | pubmed-meshheading:15812536... | lld:pubmed |
| pubmed-article:15812536 | pubmed:meshHeading | pubmed-meshheading:15812536... | lld:pubmed |
| pubmed-article:15812536 | pubmed:meshHeading | pubmed-meshheading:15812536... | lld:pubmed |
| pubmed-article:15812536 | pubmed:meshHeading | pubmed-meshheading:15812536... | lld:pubmed |
| pubmed-article:15812536 | pubmed:meshHeading | pubmed-meshheading:15812536... | lld:pubmed |
| pubmed-article:15812536 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15812536 | pubmed:articleTitle | Adenovirus infection in children after allogeneic stem cell transplantation: diagnosis, treatment and immunity. | lld:pubmed |
| pubmed-article:15812536 | pubmed:affiliation | Department of Paediatrics, Leiden University Medical Centre, Leiden, The Netherlands. M.J.D.van_Tool@LUMC.nl | lld:pubmed |
| pubmed-article:15812536 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15812536 | pubmed:publicationType | Review | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15812536 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15812536 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15812536 | lld:pubmed |
